Literature DB >> 26018727

Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists.

Elizabeth H Baldini1, Walter Bosch, John M Kane, Ross A Abrams, Kilian E Salerno, Curtiland Deville, Chandrajit P Raut, Ivy A Petersen, Yen-Lin Chen, John T Mullen, Keith W Millikan, Giorgos Karakousis, Michael L Kendrick, Thomas F DeLaney, Dian Wang.   

Abstract

PURPOSE: Curative intent management of retroperitoneal sarcoma (RPS) requires gross total resection. Preoperative radiotherapy (RT) often is used as an adjuvant to surgery, but recurrence rates remain high. To enhance RT efficacy with acceptable tolerance, there is interest in delivering "boost doses" of RT to high-risk areas of gross tumor volume (HR GTV) judged to be at risk for positive resection margins. We sought to evaluate variability in HR GTV boost target volume delineation among collaborating sarcoma radiation and surgical oncologist teams.
METHODS: Radiation planning CT scans for three cases of RPS were distributed to seven paired radiation and surgical oncologist teams at six institutions. Teams contoured HR GTV boost volumes for each case. Analysis of contour agreement was performed using the simultaneous truth and performance level estimation (STAPLE) algorithm and kappa statistics.
RESULTS: HRGTV boost volume contour agreement between the seven teams was "substantial" or "moderate" for all cases. Agreement was best on the torso wall posteriorly (abutting posterior chest abdominal wall) and medially (abutting ipsilateral para-vertebral space and great vessels). Contours varied more significantly abutting visceral organs due to differing surgical opinions regarding planned partial organ resection.
CONCLUSIONS: Agreement of RPS HRGTV boost volumes between sarcoma radiation and surgical oncologist teams was substantial to moderate. Differences were most striking in regions abutting visceral organs, highlighting the importance of collaboration between the radiation and surgical oncologist for "individualized" target delineation on the basis of areas deemed at risk and planned resection.

Entities:  

Mesh:

Year:  2015        PMID: 26018727      PMCID: PMC4684182          DOI: 10.1245/s10434-015-4633-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  34 in total

1.  Extended surgical resection and histology in retroperitoneal sarcoma.

Authors:  Aimee M Crago
Journal:  Ann Surg Oncol       Date:  2014-10-15       Impact factor: 5.344

Review 2.  Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel.

Authors:  Elizabeth H Baldini; Dian Wang; Rick L M Haas; Charles N Catton; Daniel J Indelicato; David G Kirsch; David Roberge; Kilian Salerno; Curtiland Deville; B Ashleigh Guadagnolo; Brian O'Sullivan; Ivy A Petersen; Cecile Le Pechoux; Ross A Abrams; Thomas F DeLaney
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-01       Impact factor: 7.038

3.  Improving outcomes for retroperitoneal sarcomas: a work in progress.

Authors:  Carol J Swallow; Charles N Catton
Journal:  Surg Oncol Clin N Am       Date:  2012-04       Impact factor: 3.495

4.  Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG.

Authors:  Syvie Bonvalot; Chandrajit P Raut; Raphael E Pollock; Piotr Rutkowski; Dirk C Strauss; Andrew J Hayes; Frits Van Coevorden; Marco Fiore; Eberhard Stoeckle; Peter Hohenberger; Alessandro Gronchi
Journal:  Ann Surg Oncol       Date:  2012-04-03       Impact factor: 5.344

5.  Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group.

Authors: 
Journal:  Ann Surg Oncol       Date:  2014-10-15       Impact factor: 5.344

6.  Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas.

Authors:  A Gronchi; R Miceli; C Colombo; S Stacchiotti; P Collini; L Mariani; C Sangalli; S Radaelli; R Sanfilippo; M Fiore; P G Casali
Journal:  Ann Oncol       Date:  2011-07-16       Impact factor: 32.976

7.  Tools for consensus analysis of experts' contours for radiotherapy structure definitions.

Authors:  Rawan Allozi; X Allen Li; Julia White; Aditya Apte; An Tai; Jeff M Michalski; Walter R Bosch; Issam El Naqa
Journal:  Radiother Oncol       Date:  2010-08-11       Impact factor: 6.280

8.  Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.

Authors:  S Singer; J M Corson; G D Demetri; E A Healey; K Marcus; T J Eberlein
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

9.  Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma?

Authors:  C Le Péchoux; E Musat; C Baey; H Al Mokhles; P Terrier; J Domont; A Le Cesne; A Laplanche; S Bonvalot
Journal:  Ann Oncol       Date:  2012-11-02       Impact factor: 32.976

10.  Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection?

Authors:  William W Tseng; John E Madewell; Wei Wei; Neeta Somaiah; Alexander J Lazar; Markus P Ghadimi; Aviad Hoffman; Peter W T Pisters; Dina C Lev; Raphael E Pollock
Journal:  Ann Surg Oncol       Date:  2014-04-07       Impact factor: 5.344

View more
  4 in total

1.  Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists.

Authors:  Elizabeth H Baldini; Ross A Abrams; Walter Bosch; David Roberge; Rick L M Haas; Charles N Catton; Daniel J Indelicato; Jeffrey R Olsen; Curtiland Deville; Yen-Lin Chen; Steven E Finkelstein; Thomas F DeLaney; Dian Wang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-05-01       Impact factor: 7.038

Review 2.  Advances in Radiation Therapy for Primary and Metastatic Adult Soft Tissue Sarcomas.

Authors:  Philip Blumenfeld; Neilayan Sen; Ross Abrams; Dian Wang
Journal:  Curr Oncol Rep       Date:  2016-06       Impact factor: 5.075

3.  Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas.

Authors:  Thomas F DeLaney; Yen-Lin Chen; Elizabeth H Baldini; Dian Wang; Judith Adams; Shea B Hickey; Beow Y Yeap; Stephen M Hahn; Karen De Amorim Bernstein; G Petur Nielsen; Edwin Choy; John T Mullen; Sam S Yoon
Journal:  Adv Radiat Oncol       Date:  2017-01-04

4.  Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.

Authors:  Pippa F Cosper; Jeffrey Olsen; Todd DeWees; Brian A Van Tine; William Hawkins; Jeff Michalski; Imran Zoberi
Journal:  Radiat Oncol       Date:  2017-12-08       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.